These results indicated a positive correlation of PGAM1 with unfavorable clinicopathological TNM stages (R2 = 0.46, P = 3.99e−5), thereby potentiating the role of PGAM1 as a diagnostic and prognostic marker for ESCC. This evidence concerns the gene PGAM1 and esophageal squamous cell carcinoma.